Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy
article
OA: closed
CC0
⤵ 9 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the effects of gonadotrophin-releasing hormone agonist combined with continuous combined hormone replacement therapy in severe endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (17)
- 10 LHRH analogues in the treatment of endometriosis—comparative results with other treatments via openalex
- Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. via openalex
- Endometriosis. via openalex
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
- Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists? via openalex
- Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist via openalex
- Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma via openalex
- The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
- The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
- W2408619637 via openalex
- W1997894565 via openalex
- W2086356273 via openalex
- W2416488540 via openalex
- W2419034820 via openalex
- W2466758801 via openalex
- W2157317148 via openalex
- W2053981213 via openalex
Cited by (9)
- GnRH agonists and add‐back therapy: is there a perfect combination? 1998
- Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis 1997
- The mythology of hormone replacement therapy 1997
- Goserelin 1996
- Endocrine effects of GnRH analogue with low‐dose hormone replacement therapy in women with endometriosis 1995
- Bilateral extrinsic endometriosis of the ureters with renal failure: A case report 1994
- Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic pain 1993
- An alternative to hysterectomy? GnRH analogue combined with hormone replacement therapy 1993
- Principles of medical therapy for endometriosis pain 1992
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:11:49.821429+00:00
License: CC0
· commercial use OK